---All---
  • ---All---
  • Accession
  • Catalog #

CDH11 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP18528b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP18528b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

CDH11 Antibody (C-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP55287
Other AccessionP55288, NP_001788
ReactivityHuman, Mouse
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW87965 Da

CDH11 Antibody (C-term) - Additional info

Gene ID 1009
Other Names
CDH11; Cadherin-11; OSF-4; Osteoblast cadherin
Target/Specificity
This CDH11 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 621-650 amino acids from the C-terminal region of human CDH11.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
CDH11 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

CDH11 Antibody (C-term) - Protein Information

Name CDH11
Function
Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types
Cellular Location
Cell membrane; Single-pass type I membrane protein
Tissue Location
Expressed mainly in brain but also found in other tissues. Expressed in neuroblasts

CDH11 Antibody (C-term) - Related products

AP18528b: CDH11 Antibody (C-term)

RI10940: CDH11 predesign siRNA

AT1471a: CDH11 Antibody (monoclonal) (M01)

CDH11 Antibody (C-term) - Application data

  • CDH11 Antibody (C-term) (Cat. #AP18528b) western blot analysis in mouse brain tissue lysates (35ug/lane).This demonstrates the CDH11 antibody detected the CDH11 protein (arrow).

CDH11 Antibody (C-term) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes a type II classical cadherin from the cadherin superfamily, integral membrane proteins that mediate calcium-dependent cell-cell adhesion. Mature cadherin proteins are composed of a large N-terminal extracellular domain, a single membrane-spanning domain, and a small, highly conserved C-terminal cytoplasmic domain. Type II (atypical) cadherins are defined based on their lack of a HAV cell adhesion recognition sequence specific to type I cadherins. Expression of this particular cadherin in osteoblastic cell lines, and its upregulation during differentiation, suggests a specific function in bone development and maintenance.

REFERENCES

Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Sachdeva, M., et al. Cancer Res. 70(1):378-387(2010) Canova, C., et al. Cancer Res. 69(7):2956-2965(2009) Farina, A.K., et al. PLoS ONE 4 (3), E4797 (2009) : Brieger, J., et al. APMIS 116(12):1050-1057(2008)